Turning Point Brands Announces Third Quarter 2022 Results

-Net Sales for Q3 2022 Zig-Zag and Stoker’s Products Increased 17.7 Percent Year-Over-Year

LOUISVILLE, Ky.--()--Turning Point Brands, Inc. (“TPB” or “the Company”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced today financial results for the third quarter ended September 30, 2022.

Q3 2022 vs. Q3 2021

  • Net sales decreased 1.9% to $107.8 million
    • Combined net sales increased 17.7% for Zig-Zag and Stoker’s Products (increased 23.3% and 10.0%, respectively)
    • NewGen net sales declined by 40.3% (declined 3.9% sequentially)
  • Gross profit decreased 2.9% to $52.7 million
  • Net income decreased 14.3% to $11.5 million
  • Adjusted EBITDA decreased 6.7% to $24.5 million (see Schedule A for a reconciliation to net income)
  • Diluted EPS of $0.60 and Adjusted Diluted EPS of $0.72 compared to $0.65 and $0.72 in the same period one year ago, respectively (see Schedule B for a reconciliation to Diluted EPS)

“Zig-Zag and Stoker’s segments demonstrated strong double-digit growth during the quarter despite a challenging economic backdrop with inflationary pressures continuing to impact consumers. Zig-Zag benefitted from solid growth in the U.S. papers and Canadian businesses during the quarter and the successful launch of CLIPPER lighters. Meanwhile, Stoker’s MST experienced continued share gains driven by consumer trade-down to the value category. NewGen sales decreased slightly compared to the previous quarter and the segment remained profitable as we monitor ongoing regulatory developments,” said Graham Purdy, President and CEO. “We continued to return capital to our shareholders during the quarter while maintaining a strong cash balance that provides us with the ability to navigate the current financing environment. While our competitive position remains strong and we outperformed our markets during the quarter, it is prudent to adjust our outlook for the year in light of the current economic environment.”

Mr. Purdy continued, “After 18 years with the Company, I am very excited to have the opportunity to lead our team to drive organic growth and create shareholder value.”

Zig-Zag Products Segment (48% of total net sales in the quarter)

For the third quarter, Zig-Zag Products net sales increased 23.3% to $52.1 million. Both of TPB’s U.S. rolling papers and e-commerce, and other smoking accessories businesses grew by double-digits during the quarter. Continued strength in paper cones, strong receptivity to promotional programs, the launch of CLIPPER lighters, and timing shifts in Canadian deliveries contributed to strong performance during the quarter. In total, the Company believes approximately $5 million of sales was pulled forward from the fourth quarter across the Zig Zag portfolio. For the third quarter, total Zig-Zag Products segment volume increased 21.7%, while price / mix increased 1.6%.

For the quarter, the Zig-Zag Products segment gross profit increased 18.3% to $28.0 million. The segment’s gross margin declined 220 basis points to 53.9% driven primarily by product mix including the launch of our lighters business.

“New product offerings such as our paper cones and Zig-Zag’s fast growing alternative channel business continue to drive growth and market outperformance within our U.S. papers business,” said Purdy. “In addition, we are very excited by the launch of CLIPPER lighters during the quarter which resulted in one of the most successful new product roll-out in our company’s history. The initial reception supports our conviction that the lighters business will be a major driver of Zig-Zag segment growth for the foreseeable future.”

Stoker’s Products Segment (31% of total net sales in the quarter)

For the third quarter, Stoker’s Products net sales increased 10.0% to $33.5 million on strong double-digit growth of MST partially offset by a mid-single digit decline in loose-leaf chewing tobacco. FRE nicotine pouch product was a marginal contributor to segment sales. For the third quarter, total Stoker’s Products segment volume increased 2.4%, while price / mix increased 7.6%.

For the quarter, the Stoker’s Products segment gross profit increased 6.9% to $18.3 million. The segment’s gross margin contracted 160 basis points to 54.5% primarily due to the mix impact of FRE and stronger growth in discount looseleaf products.

“Stoker’s market share gains in both the MST and loose-leaf chewing tobacco categories continued during the quarter,” continued Purdy. “Stoker’s remains well-positioned within its categories as a leading value brand which we believe is helping drive sales due to consumer downtrading in the current economic environment. Our outlook for our MST business remains solid driven by continued growth in in-store market share, distribution gains, and favorable category pricing.”

NewGen Products Segment (21% of total net sales in the quarter)

For the third quarter, NewGen Products net sales decreased 40.3% to $22.2 million. The regulatory environment continues to impact sales. Net sales have been relatively steady sequentially within the current year period.

For the quarter, NewGen Products segment gross profit decreased 52.5% to $6.4 million. The segment gross margin contracted 740 basis points from the previous year to 28.8% due to product mix and the competitive environment.

“The NewGen Products business had another challenging quarter but remained profitable as we await developments from the FDA on the PMTA process,” concluded Purdy.

Performance Measures in the Third Quarter

Third quarter consolidated selling, general and administrative (“SG&A”) expenses were $32.9 million compared to $31.9 million in the third quarter of 2021.

The third quarter SG&A included the following notable items:

  • $0.4 million of ERP / CRM scoping expenses and duplicative system costs compared to none in the previous year
  • $1.4 million of stock options, restricted stock and incentive expense compared to $1.8 million in the year-ago period
  • $1.2 million of FDA PMTA-related expenses compared to $1.0 million in the year-ago period
  • $2.3 million Turning Point Brands Canada compared to $1.5 in the year-ago period

Total gross debt as of September 30, 2022 was $422.5 million. The corresponding net debt (total gross debt less cash) at September 30, 2022 was $316.8 million. The Company ended the quarter with total liquidity of $127.1 million, comprised of $105.7 million in cash and $21.4 million of revolving credit facility capacity.

During the quarter, the Company spent $7.6 million to repurchase 307,207 shares at an average price of $24.78 per share.

2022 Outlook

As previously disclosed in our October 17, 2022 press release, the Company expects the following full-year 2022 results:

  • Zig-Zag Products sales of $186 to $191 million (compared to previous outlook of $193 to $200 million)
  • Stoker's Products sales of $128 to $132 million (compared to previous outlook of $127 to $133 million)
  • Consolidated adjusted EBITDA of $96 to $99 million (compared to previous outlook of $97 to $103 million)

Earnings Conference Call

As previously disclosed, a conference call with the investment community to review TPB’s financial results has been scheduled for 8:30 a.m. Eastern on Wednesday, October 26, 2022. Investment community participants should dial in 10 minutes ahead of time using the toll-free number 888-330-2502 (international participants should call 240-789-2713), and follow the audio prompts after typing in the event ID: 6640134. A live listen-only webcast of the call will be available on the Events and Presentations section of the investor relations portion of the Company website (www.turningpointbrands.com). A replay of the webcast will be available on the site two hours following the call.

Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles in the United States (GAAP), this press release includes certain non-GAAP financial measures including EBITDA, Adjusted EBITDA, Adjusted diluted EPS and Adjusted Operating Income. A reconciliation of these non-GAAP financial measures accompanies this release.

About Turning Point Brands, Inc.

Turning Point Brands (NYSE: TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic Zig-Zag® and Stoker’s® brands, and its emerging brands within the NewGen segment. TPB’s products are available in more than 215,000 retail outlets in North America, and on sites such as www.zigzag.com and www.solacevapor.com. For the latest news and information about TPB and its brands, please visit www.turningpointbrands.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by TPB in this press release, its reports filed with the Securities and Exchange Commission (the “SEC”) and other public statements made from time-to-time speak only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict or identify all such events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to those included it the Company’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by the Company with the SEC. These statements constitute the Company’s cautionary statements under the Private Securities Litigation Reform Act of 1995.

Financial Statements Follow:

Turning Point Brands, Inc.

Consolidated Statements of Income

(dollars in thousands except share data)

(unaudited)

 

Three Months Ended September 30,

2022

2021

 
Net sales

$

107,802

 

$

109,904

 

Cost of sales

 

55,090

 

 

55,635

 

Gross profit

 

52,712

 

 

54,269

 

Selling, general, and administrative expenses

 

32,891

 

 

31,894

 

Operating income

 

19,821

 

 

22,375

 

Interest expense, net

 

4,802

 

 

5,397

 

Investment income

 

(75

)

 

(157

)

Gain on extinguishment of debt

 

-

 

 

(375

)

Income before income taxes

 

15,094

 

 

17,510

 

Income tax expense

 

3,797

 

 

4,073

 

Consolidated net income

 

11,297

 

 

13,437

 

Net loss attributable to non-controlling interest

 

(239

)

 

(31

)

Net income attributable to Turning Point Brands, Inc.

$

11,536

 

$

13,468

 

 
Basic income per common share:
Net income attributable to Turning Point Brands, Inc.

$

0.65

 

$

0.71

 

Diluted income per common share:
Net income attributable to Turning Point Brands, Inc.

$

0.60

 

$

0.65

 

Weighted average common shares outstanding:
Basic

 

17,749,294

 

 

18,897,974

 

Diluted

 

21,102,006

 

 

22,364,807

 

 
Supplemental disclosures of statements of income information:
Excise tax expense

$

5,747

 

$

6,040

 

FDA fees

$

170

 

$

163

 

Turning Point Brands, Inc.
Consolidated Balance Sheets
(dollars in thousands except share data)
 
(unaudited)
September 30, December 31,
ASSETS

2022

2021

Current assets:
Cash

$

105,672

 

$

128,320

 

Accounts receivable, net of allowances of $107 in 2022 and $262 in 2021

 

11,453

 

 

6,496

 

Inventories

 

113,928

 

 

87,607

 

Other current assets

 

24,729

 

 

26,746

 

Total current assets

 

255,782

 

 

249,169

 

Property, plant, and equipment, net

 

22,512

 

 

18,650

 

Deferred income taxes

 

2,795

 

 

1,363

 

Right of use assets

 

13,185

 

 

15,053

 

Deferred financing costs, net

 

309

 

 

388

 

Goodwill

 

162,120

 

 

162,333

 

Other intangible assets, net

 

86,112

 

 

87,485

 

Master Settlement Agreement (MSA) escrow deposits

 

27,845

 

 

31,720

 

Other assets

 

29,129

 

 

35,399

 

Total assets

$

599,789

 

$

601,560

 

 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

$

9,247

 

$

7,361

 

Accrued liabilities

 

32,613

 

 

32,937

 

Other current liabilities

 

21

 

 

38

 

Total current liabilities

 

41,881

 

 

40,336

 

Notes payable and long-term debt

 

416,029

 

 

414,172

 

Lease liabilities

 

11,299

 

 

13,336

 

Total liabilities

 

469,209

 

 

467,844

 

 
Commitments and contingencies
 
Stockholders' equity:
Preferred stock; $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-

 

-

 

 

-

 

Common stock, voting, $0.01 par value; authorized shares, 190,000,000; 19,801,623 issued shares and 17,587,122 outstanding shares at September 30, 2022, and 19,690,884 issued shares and 18,395,476 outstanding shares at December 31, 2021

 

198

 

 

197

 

Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000; issued and outstanding shares -0-

 

-

 

 

-

 

Additional paid-in capital

 

112,034

 

 

108,811

 

Cost of repurchased common stock (2,214,501 shares at September 30, 2022 and 1,295,408 shares at December 31, 2021)

 

(75,901

)

 

(48,869

)

Accumulated other comprehensive loss

 

(3,424

)

 

(195

)

Accumulated earnings

 

96,088

 

 

71,460

 

Non-controlling interest

 

1,585

 

 

2,312

 

Total stockholders' equity

 

130,580

 

 

133,716

 

Total liabilities and stockholders' equity

$

599,789

 

$

601,560

 

Turning Point Brands, Inc.
Consolidated Statements of Cash Flows
(dollars in thousands)
(unaudited)
 

Nine Months Ended September 30,

2022

 

2021

Cash flows from operating activities:
Consolidated net income

$

27,274

 

$

40,007

 

Adjustments to reconcile net income to net cash provided by operating activities:
Loss on extinguishment of debt

 

-

 

 

5,331

 

Gain on sale of property, plant, and equipment

 

(8

)

 

(2

)

Depreciation expense

 

2,611

 

 

2,313

 

Amortization of other intangible assets

 

1,373

 

 

1,431

 

Amortization of deferred financing costs

 

1,936

 

 

1,895

 

Deferred income tax (benefit) expense

 

(431

)

 

1,528

 

Stock compensation expense

 

4,103

 

 

6,015

 

Noncash lease income

 

-

 

 

(49

)

Loss (gain) on investments

 

6,244

 

 

(144

)

Changes in operating assets and liabilities:
Accounts receivable

 

(5,030

)

 

1,324

 

Inventories

 

(26,467

)

 

(10,970

)

Other current assets

 

1,891

 

 

(491

)

Other assets

 

1,211

 

 

685

 

Accounts payable

 

2,074

 

 

3,488

 

Accrued liabilities and other

 

(392

)

 

(2,796

)

Net cash provided by operating activities

$

16,389

 

$

49,565

 

 
Cash flows from investing activities:
Capital expenditures

$

(6,662

)

$

(4,391

)

Acquisitions, net of cash acquired

 

-

 

 

(16,416

)

Payments for investments

 

(1,000

)

 

(16,657

)

Restricted cash, MSA escrow deposits

 

(10,169

)

 

(14,783

)

Proceeds on the sale of property, plant and equipment

 

63

 

 

2

 

Net cash used in investing activities

$

(17,768

)

$

(52,245

)

 
Cash flows from financing activities:
Proceeds from Senior Secured Notes

$

-

 

$

250,000

 

Payments of 2018 first lien term loan

 

-

 

 

(130,000

)

Settlement of interest rate swaps

 

-

 

 

(3,573

)

Payment of promissory note

 

-

 

 

(9,625

)

Payment of dividends

 

(3,259

)

 

(3,056

)

Payments of financing costs

 

-

 

 

(6,921

)

Exercise of options

 

504

 

 

2,071

 

Redemption of options

 

(155

)

 

(2,111

)

Redemption of stock units

 

(1,228

)

 

-

 

Common stock repurchased

 

(27,032

)

 

(20,481

)

Net cash (used in) provided by financing activities

$

(31,170

)

$

76,304

 

 
Net (decrease) increase in cash

$

(32,549

)

$

73,624

 

Effect of foreign currency translation on cash

$

(324

)

$

235

 

 
Cash, beginning of period:
Unrestricted

 

128,320

 

 

41,765

 

Restricted

 

15,155

 

 

35,074

 

Total cash at beginning of period

 

143,475

 

 

76,839

 

 
Cash, end of period:
Unrestricted

 

105,672

 

 

130,551

 

Restricted

 

4,930

 

 

20,147

 

Total cash at end of period

$

110,602

 

$

150,698

 

Non-GAAP Financial Measures

To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures, including EBITDA, Adjusted EBITDA, Adjusted diluted EPS, and Adjusted Operating Income. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA, Adjusted diluted EPS, and Adjusted Operating Income are used by management to compare our performance to that of prior periods for trend analyses and planning purposes and are presented to our board of directors. We believe that EBITDA, Adjusted EBITDA, Adjusted diluted EPS and Adjusted Operating Income are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to business performance.

We define “EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation and amortization. We define “Adjusted EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define “Adjusted diluted EPS” as diluted earnings per share excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define “Adjusted Operating Income” as operating income excluding other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance.

Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. EBITDA, Adjusted EBITDA Adjusted diluted EPS and Adjusted Operating Income exclude significant expenses that are required by U.S. GAAP to be recorded in our financial statements and is subject to inherent limitations. In addition, other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure.

In accordance with SEC rules, we have provided, in the supplemental information attached, a reconciliation of the non-GAAP measures to the next directly comparable GAAP measures.

Schedule A
 
Turning Point Brands, Inc.
Reconciliation of GAAP Net Income to Adjusted EBITDA
(dollars in thousands)
(unaudited)

Three Months Ended

September 30,

2022

 

2021

Net income attributable to Turning Point Brands, Inc.

$

11,536

$

13,468

 

Add:
Interest expense, net

 

4,802

 

5,397

 

Gain on extinguishment of debt

 

-

 

(375

)

Income tax expense

 

3,797

 

4,073

 

Depreciation expense

 

861

 

767

 

Amortization expense

 

454

 

477

 

EBITDA

$

21,450

$

23,807

 

Components of Adjusted EBITDA
Corporate restructuring (a)

 

17

 

-

 

ERP/CRM (b)

 

435

 

-

 

Stock options, restricted stock, and incentives expense (c)

 

1,442

 

1,752

 

Transactional expenses (d)

 

-

 

(232

)

FDA PMTA (e)

 

1,169

 

960

 

Adjusted EBITDA

$

24,513

$

26,287

 

 
 
(a) Represents costs associated with corporate restructuring, including severance.
(b) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.
(c) Represents non-cash stock options, restricted stock, incentives expense and Solace performance stock units.
(d) Represents the fees incurred for transaction expenses.
(e) Represents costs associated with applications related to FDA premarket tobacco product application ("PMTA").
Schedule B
 
Turning Point Brands
Reconciliation of GAAP diluted EPS to Adjusted diluted EPS
(dollars in thousands except share data)
(unaudited)

Three Months Ended

September 30,

2022

 

2021

GAAP EPS

$

0.60

$

0.65

 

Gain on extinguishment of debt (a)

 

-

 

(0.01

)

Corporate restructuring (b)

 

0.00

 

-

 

ERP/CRM (c)

 

0.02

 

-

 

Stock options, restricted stock, and incentives expense (d)

 

0.05

 

0.06

 

Transactional expenses (e)

 

-

 

(0.01

)

FDA PMTA (f)

 

0.04

 

0.03

 

Tax (expense) benefit (g)

 

0.01

 

0.00

 

Adjusted diluted EPS

$

0.72

$

0.72

 

 
 
Totals may not foot due to rounding
(a) Represents gain on extinguishment of debt tax effected at the quarterly tax rate.
(b) Represents costs associated with corporate restructuring, including severance, tax effected at the quarterly tax rate.
(c) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses tax effected at the quarterly tax rate.
(d) Represents non-cash stock options, restricted stock, incentives expense and Solace PRSUs tax effected at the quarterly tax rate.
(e) Represents the fees incurred for transaction expenses tax effected at the quarterly tax rate.
(f) Represents costs associated with applications related to the FDA PMTA tax effected at the quarterly tax rate.
(g) Represents adjustment from quarterly tax rate to annual projected tax rate of 23% in 2022 and 2021.
Schedule C
 
Turning Point Brands, Inc.
Reconciliation of GAAP Operating Income to Adjusted Operating Income
(dollars in thousands)
(unaudited)

Consolidated

 

Zig-Zag Products

 

Stoker's Products

 

NewGen Products

3rd Quarter

 

3rd Quarter

 

3rd Quarter

 

3rd Quarter

 

3rd Quarter

 

3rd Quarter

 

3rd Quarter

 

3rd Quarter

2022

 

2021

 

2022

 

2021

 

2022

 

2021

 

2022

 

2021

 
Net sales

$

107,802

$

109,904

 

$

52,061

$

42,234

$

33,525

$

30,472

$

22,216

$

37,198

 
Gross profit

$

52,712

$

54,269

 

$

28,035

$

23,703

$

18,279

$

17,104

$

6,398

$

13,462

 
Operating income

$

19,821

$

22,375

 

$

18,740

$

17,122

$

13,653

$

13,305

$

142

$

2,027

Adjustments:
Corporate restructuring

 

17

 

-

 

 

-

 

-

 

-

 

-

 

-

 

-

ERP/CRM

 

435

 

-

 

 

-

 

-

 

-

 

-

 

-

Transactional expenses

 

-

 

(232

)

 

-

 

-

 

-

 

-

 

-

 

-

FDA PMTA

 

1,169

 

960

 

 

-

 

-

 

-

 

-

 

-

 

-

Adjusted operating income

$

21,442

$

23,103

 

$

18,740

$

17,122

$

13,653

$

13,305

$

142

$

2,027

 

Contacts

Investor Contacts
Turning Point Brands, Inc.:
Louie Reformina, Senior Vice President, CFO
Turning Point Brands, Inc.
502.774.9238
ir@tpbi.com

Contacts

Investor Contacts
Turning Point Brands, Inc.:
Louie Reformina, Senior Vice President, CFO
Turning Point Brands, Inc.
502.774.9238
ir@tpbi.com